AKT1 and hepatocellular carcinoma: These results suggested that the PI3K-AKT pathway is associated with Lenvatinib resistance in HCC cells, and led us to focus on the EGFR-PI3K-AKT pathway and examine the effects of Curcumin for its ability to suppress this signaling pathway.